Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: a retrospective cohort study

Name: Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: a retrospective cohort study
Creator: Peng Qu
Published: 2024-04-02T15:09:40.520Z
Keywords: Clinical Medicine

Qu, Peng

doi:10.17632/myzc6gsmh9.1

Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: a retrospective cohort study

Published: 2 April 2024| Version 1 | DOI: 10.17632/myzc6gsmh9.1

Contributor:

Peng Qu

Description

Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: a retrospective cohort study

Files

Institutions

Southern Medical University Nanfang Hospital

Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: a retrospective cohort study

Description

Files

Institutions

Categories

Licence